Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pharming Group (DE:PHGN)
FRANKFURT:PHGN
Holding DE:PHGN?
Track your performance easily
PHGN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.65 - €1.19
Previous Close€0.73
Volume0.00
Average Volume (3M)7.48K
Market Cap
€491.47M
Enterprise Value€452.14M
Total Cash (Recent Filing)$213.42M
Total Debt (Recent Filing)$171.54M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Mar 13, 2025EPS Estimate
>-€0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding652,414,282
10 Day Avg. Volume1,158
30 Day Avg. Volume7,482
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.23
Price to Sales (P/S)4.64
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.33
Enterprise Value/Gross Profit2.05
Enterprise Value/Ebitda12.75
Forecast
1Y Price Target
€1.60Price Target Upside118.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Pharming Group News
PremiumCompany Announcements
Pharming Group’s Strong Q3 and CEO Transition
PremiumCompany Announcements
Pharming Group Announces Q3 2024 Financial Results
PremiumCompany Announcements
Pharming Group Begins Leniolisib Phase II Trial
PremiumCompany Announcements
Pharming Group’s New APDS Drug Wins U.K. Approval
PremiumCompany Announcements
Pharming Group Sees Strong Revenue Growth in Q2Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.49% Mutual Funds
― Other Institutional Investors
96.98% Public Companies and
Individual Investors
PHGN FAQ
What was Pharming Group’s price range in the past 12 months?
Pharming Group lowest stock price was €0.65 and its highest was €1.19 in the past 12 months.
What is Pharming Group’s market cap?
Currently, no data Available
When is Pharming Group’s upcoming earnings report date?
Pharming Group’s upcoming earnings report date is Mar 13, 2025 which is in 119 days.
How were Pharming Group’s earnings last quarter?
Pharming Group released its earnings results on Oct 24, 2024. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of €0 by -€0.002.
Is Pharming Group overvalued?
According to Wall Street analysts Pharming Group’s price is currently Undervalued.
Does Pharming Group pay dividends?
Pharming Group does not currently pay dividends.
What is Pharming Group’s EPS estimate?
Pharming Group’s EPS estimate is >-€0.01.
How many shares outstanding does Pharming Group have?
Pharming Group has 678,354,300 shares outstanding.
What happened to Pharming Group’s price movement after its last earnings report?
Pharming Group reported an EPS of -€0.002 in its last earnings report, missing expectations of €0. Following the earnings report the stock price went up 0.12%.
Which hedge fund is a major shareholder of Pharming Group?
Currently, no hedge funds are holding shares in DE:PHGN
---
Pharming Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.28%
12-Months-Change
Fundamentals
Return on Equity
-7.98%
Trailing 12-Months
Asset Growth
-2.51%
Trailing 12-Months
Company Description
Pharming Group
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.
---
PHGN Company Deck
---
PHGN Earnings Call
Q3 2024
0:00 / 0:00
---
PHGN Stock 12 Month Forecast
Average Price Target
€1.60
▲(118.85% Upside)
Technical Analysis
Pharming Group
―
ADMA Biologics
―
Avadel Pharmaceuticals
―
Clearside Biomedical
―
Opus Genetics
―
Best Analysts Covering PHGN
1 Year
1 Year Success Rate
0/10 ratings generated profit
1 Year Average Return
-27.46%
reiterated a buy rating 10 days ago
Copying Alistair Campbell's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -27.46% per trade.
---